- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02167724
Multicentre Evaluation of Bucco-dental Health in Patients With Schizophrenia in Côte d'Or (BUCCODOR)
February 5, 2026 updated by: Centre Hospitalier Universitaire Dijon
The aim of this study is to know the bucco-dental status of patients with schizophrenia in Côte d'Or.
Participation in this study will last only as long as it takes to:
- carry out a bucco-dental examination: evaluation of dental plaque and calculus
- take a blood sample to assess needs in vitamin C (only for patients included at DIJON CHU and CHS Chartreuse)
- complete a 30-minute questionnaire: clinical data and answers to questions concerning dental hygiene and eating habits.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
110
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Dijon, France, 21079
- CHU de Dijon
-
Dijon, France, 21033
- CHS La Chartreuse
-
Semur-en-Auxois, France, 21140
- CH Semur-en-Auxois
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Description
Inclusion Criteria:
- Patients who have provided consent
- Patients over 18 years of age
- Persons with schizophrenia according to the ICD 10 criteria and followed in hospital (complete or day hospital) in one of the hospitals taking part in the study
Exclusion Criteria:
- Adult under guardianship
- Patient not covered by national health insurance
- Pregnant or breast-feeding women
- Patients not stabilized from a psychiatric viewpoint
- Patients experiencing an acute psychiatric episode
- Impossibility to understand and /or poor understanding of French
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patients with schizophrenia
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Calculate the DMF index (Decayed, Missing, Filled)
Time Frame: Baselines
|
Baselines
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Calculate the simplified Oral Health Index (OHI-S)
Time Frame: Baselines
|
Baselines
|
|
Perception of oral health of patients observed
Time Frame: Baselines
|
Baselines
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
January 1, 2016
Study Completion (Actual)
January 1, 2016
Study Registration Dates
First Submitted
June 17, 2014
First Submitted That Met QC Criteria
June 17, 2014
First Posted (Estimated)
June 19, 2014
Study Record Updates
Last Update Posted (Actual)
February 9, 2026
Last Update Submitted That Met QC Criteria
February 5, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DENIS CHS 2014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States, India
-
Bradley LegaRecruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Kaohsiung Medical University Chung-Ho Memorial...Not yet recruitingSchizophrenia Disorder
-
Shanghai Zhongze Therapeutics Co., Ltd.Yale UniversityNot yet recruiting
-
Ole Köhler-ForsbergAarhus University HospitalRecruiting
Clinical Trials on Blood sample
-
Institut PasteurCentre Terrritorial Hospitalier Gaston BourretNot yet recruiting
-
First Affiliated Hospital of Zhejiang UniversityRecruitingComplication | Hematologic Malignancy | Hematopoietic Stem Cell Transplantation | Chronic Graft-versus-host-diseaseChina
-
University Hospital, BordeauxMinistry for Health and Solidarity, FranceRecruitingImmune Thrombocytopenia | Autoimmune Hemolytic Anemia | Autoimmune NeutropeniaFrance
-
University Hospital, ToursCompletedMetastatic Prostate Cancer | Circulating Tumor DNAFrance
-
University Hospital, BordeauxCompletedRenal Function Disorder | Chronic Renal Diseases
-
Medical University of WarsawCompletedArthroplasty | Platelet Aggregation | Methylmethacrylate EmbolismPoland
-
Stanford UniversityWithdrawnNeuroendocrine Tumors | Carcinoid TumorUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedAcute Myeloid LeukemiaUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruitingGraft Vs Host DiseaseChina
-
Centre Hospitalier Universitaire DijonRecruiting